Home > Healthcare > Analytical Instruments > Molecular Analysis > Flow Cytometry Market

Flow Cytometry Market Trends

Report ID: GMI5897
Published Date: May 2023
Report Format: PDF

Download Free Sample

Flow Cytometry Market Trends

Technological advancements have significantly improved flow cytometry instruments, enhancing their capabilities and performance. High-parameter and multiplexing capabilities, automation and high-throughput analysis, imaging flow cytometry and improvements in optics, detectors, and signal processing are among the key parameters that are anticipated to fuel the product adoption rate. Flow cytometry instruments have evolved to accommodate higher parameter analysis, allowing simultaneous detection of more fluorescent markers.

In addition, major companies around the world are focusing on using flow cytometry while conducting research related to different fields. For instance, in October 2021, BD Life Sciences-Biosciences, in partnership with the Christian Medical College Vellore India, launched its second (CoE) center of excellence related to flow cytometry for clinical research. Such developments by leading players will enhance the flow cytometry systems adoption rate, thereby augmenting the market statistics.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The market valuation of flow cytometry crossed USD 4.9 billion in 2022 and is estimated to exceed USD 11.2 billion by 2032 driven by technological advancements, growing biomedical research, increasing focus on personalized medicine, and a rise in cancer research and immunotherapy.

The instrument segment generated around USD 1.6 billion in 2022 and is anticipated to grow at a robust pace through 2032 owing to a wide application range, technological advancements, and increased research spending by multinational companies.

North America flow cytometry industry is expected to register gains at nearly 7.8% from 2023 to 2032 attributed to the expanding application prospect of flow cytometry in clinical settings, high disease burden rate, and increased R&D spending.

Some of the prominent firms engaged in the global market are Sony Biotechnology, Inc., Becton, Dickinson and Company, Danaher Corp, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Miltenyi Biotec, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, and Luminex Corporation, among others.